News
Filter
-
Charity seeks diagnostic partners to deliver new patient treatments
-
MRC Technology strengthens its collaborative relationships in Scandinavia
-
Dementia Consortium signs new pharma partner Astex Pharmaceuticals
-
Charity and academic collaboration aims to find drug treatment for lymphoma
-
EU Consortium receives funding for detection and prevention of diseases associated with ageing
-
Dementia Consortium funds project focusing on ALS and FTLD
-
NICE recommends pembrolizumab made available on the NHS for advanced skin cancer (antibody humanized by MRC Technology)
-
Georg-August-University Göttingen, Universitätsmedizin and MRC Technology collaborate to develop new therapy for neurodegenerative diseases
-
Keytruda receives EU marketing approval (antibody humanised by MRC Technology)
-
MRC Technology appoints technology transfer director
-
Brain inflammation targeted in first drug discovery project from £3m Dementia Consortium
-
MRC Technology and Peptinnovate collaborate on therapeutics for bone diseases
